CapitalUnited States
Nvidia-backed AI drug developer Iambic raises $150m in IPO
Useful

Iambic said it will use the proceeds to advance three early-stage cancer drug candidates.
CapitalUnited States

Iambic said it will use the proceeds to advance three early-stage cancer drug candidates.